Home » Topics » BioWorld Science

BioWorld Science
RSS

WestVac BioPharma's COVID-19 vaccine shows high titer neutralizing antibodies against Omicron

Dec. 24, 2021

Evusheld retains neutralizing activity against Omicron variant

Dec. 24, 2021

Gene expression of extramedullary multiple myeloma samples points to new targets

Dec. 24, 2021

Anti-CD47 antibody ADG-153 shows promising preclinical data for cancer immunotherapy

Dec. 24, 2021

New USP30 inhibitors identified at Mission Therapeutics

Dec. 24, 2021

Janssen Pharmaceutica synthesizes new Mcl-1 inhibitors

Dec. 24, 2021

Trinuero, DGMIF identify SERT, NET and DAT inhibitors

Dec. 24, 2021

CSIPI and Shanghai Zhongze Therapeutics patent dopamine D2/D3/5-HT2A receptor antagonists

Dec. 24, 2021

Dual PI3K/BRD4 inhibitors divulged by Monash University, Peter MacCallum Cancer Centre

Dec. 24, 2021

Alphataxin increases CD4+ tumor-infiltrating T cells and suppresses renal cell cancer in mice

Dec. 24, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 3, 2026.
ASCO 2026: A revolution in pancreatic cancer
BioWorld
At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
EASL 2026: Emerging liver disease targets to watch
BioWorld
At the recently concluded European Association for the Study of the Liver meeting, presentations underscored how increasingly granular insights into liver...
ASCO 2026: PD-(L)1 x VEGF bispecifics fight it out
BioWorld
Multiple companies are chasing Akeso Inc. and Summit Therapeutics Inc. in the battle to potentially dethrone Keytruda (pembrolizumab, Merck & Co. Inc.) as the top...